Rabin Medical Center, Campus Beilinson
Welcome,         Profile    Billing    Logout  
 18 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Singer, Pierre
NCT04612413: A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients

Active, not recruiting
2
160
Europe, RoW
Allocetra-OTS, Placebo
Enlivex Therapeutics Ltd., Cato Research, Accelsiors CRO & Consultancy Services
Sepsis, Community-acquired Pneumonia, Urinary Tract Infections, Cholecystitis, Acute, Cholangitis Acute, Intraabdominal Infections
12/24
03/25
Kagan, Ilya
NCT04731116: Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection

Recruiting
1/2
40
RoW
Cannabidiol
Rabin Medical Center
COVID-19
12/21
04/22
BALANCE, NCT03005145: Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness

Completed
N/A
3622
Europe, Canada, US, RoW
7 days of adequate antibiotic treatment, 14 days of adequate antibiotic treatment.
Sunnybrook Health Sciences Centre
Bacteremia, Intensive Care, Critically Ill, Sepsis, Mortality, Antimicrobial
05/23
08/23
Katz, Miriam Ben Harosh
No trials found
Grinev, Milana
No trials found
Theilla, Miriam
No trials found
Haim, Shapiro
No trials found
Anbar, Ronit
No trials found
Pinsker, Dana
No trials found
Shapiro, Niva
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Singer, Pierre
NCT04612413: A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients

Active, not recruiting
2
160
Europe, RoW
Allocetra-OTS, Placebo
Enlivex Therapeutics Ltd., Cato Research, Accelsiors CRO & Consultancy Services
Sepsis, Community-acquired Pneumonia, Urinary Tract Infections, Cholecystitis, Acute, Cholangitis Acute, Intraabdominal Infections
12/24
03/25
Kagan, Ilya
NCT04731116: Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection

Recruiting
1/2
40
RoW
Cannabidiol
Rabin Medical Center
COVID-19
12/21
04/22
BALANCE, NCT03005145: Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness

Completed
N/A
3622
Europe, Canada, US, RoW
7 days of adequate antibiotic treatment, 14 days of adequate antibiotic treatment.
Sunnybrook Health Sciences Centre
Bacteremia, Intensive Care, Critically Ill, Sepsis, Mortality, Antimicrobial
05/23
08/23
Katz, Miriam Ben Harosh
No trials found
Grinev, Milana
No trials found
Theilla, Miriam
No trials found
Haim, Shapiro
No trials found
Anbar, Ronit
No trials found
Pinsker, Dana
No trials found
Shapiro, Niva
No trials found

Download Options